Brentuximab vedotin
C25029
Approved small_molecule completed
Quick answer
Brentuximab vedotin for T-Cell Lymphoma is a Approved program (small_molecule) at Takeda with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- T-Cell Lymphoma
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed